Phase-II trial of rebeccamycin analog, a dual topoisomerase-I and -II inhibitor, in relapsed "sensitive" small cell lung cancer

Anita Schwandt, Tarek Mekhail, Balazs Halmos, Timothy O'Brien, Patrick C. Ma, Pingfu Fu, Percy Ivy, Afshin Dowlati

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'Phase-II trial of rebeccamycin analog, a dual topoisomerase-I and -II inhibitor, in relapsed "sensitive" small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences